Free Trial

Lecap Asset Management Ltd. Has $730,000 Position in UiPath, Inc. (NYSE:PATH)

UiPath logo with Computer and Technology background

Lecap Asset Management Ltd. lessened its stake in UiPath, Inc. (NYSE:PATH - Free Report) by 39.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 70,828 shares of the company's stock after selling 45,461 shares during the quarter. Lecap Asset Management Ltd.'s holdings in UiPath were worth $730,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Archford Capital Strategies LLC lifted its stake in UiPath by 68.4% in the 1st quarter. Archford Capital Strategies LLC now owns 98,733 shares of the company's stock valued at $1,017,000 after purchasing an additional 40,109 shares during the last quarter. Palumbo Wealth Management LLC boosted its stake in shares of UiPath by 41.0% during the 1st quarter. Palumbo Wealth Management LLC now owns 15,982 shares of the company's stock worth $165,000 after acquiring an additional 4,645 shares during the period. Stanley Laman Group Ltd. increased its holdings in shares of UiPath by 111.8% during the 1st quarter. Stanley Laman Group Ltd. now owns 736,960 shares of the company's stock worth $7,591,000 after acquiring an additional 388,971 shares during the last quarter. NorthCrest Asset Manangement LLC increased its holdings in shares of UiPath by 87.8% during the 1st quarter. NorthCrest Asset Manangement LLC now owns 20,929 shares of the company's stock worth $216,000 after acquiring an additional 9,782 shares during the last quarter. Finally, Fort Washington Investment Advisors Inc. OH raised its stake in UiPath by 100.0% in the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 85,290 shares of the company's stock valued at $878,000 after acquiring an additional 42,645 shares during the period. 62.50% of the stock is owned by institutional investors.

Analysts Set New Price Targets

PATH has been the subject of a number of research analyst reports. Needham & Company LLC reaffirmed a "hold" rating on shares of UiPath in a research report on Friday, May 30th. Truist Financial raised their target price on shares of UiPath from $12.00 to $13.00 and gave the stock a "hold" rating in a research note on Friday, May 30th. Bank of America reiterated an "underperform" rating and issued a $10.00 price target (down previously from $18.00) on shares of UiPath in a research note on Thursday, March 13th. Evercore ISI increased their target price on UiPath from $11.00 to $15.00 and gave the stock an "in-line" rating in a research note on Friday, May 30th. Finally, Canaccord Genuity Group set a $16.00 price target on shares of UiPath and gave the stock a "buy" rating in a research report on Monday, June 2nd. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, UiPath presently has a consensus rating of "Hold" and a consensus target price of $13.83.

Read Our Latest Analysis on PATH

UiPath Stock Performance

Shares of NYSE PATH traded up $0.32 during trading hours on Thursday, hitting $12.79. 6,958,334 shares of the stock were exchanged, compared to its average volume of 10,403,686. The company's fifty day simple moving average is $12.30 and its two-hundred day simple moving average is $12.54. The company has a market cap of $6.84 billion, a PE ratio of -106.53, a price-to-earnings-growth ratio of 16.39 and a beta of 1.06. UiPath, Inc. has a 1-year low of $9.38 and a 1-year high of $15.93.

UiPath (NYSE:PATH - Get Free Report) last released its earnings results on Thursday, May 29th. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.01. UiPath had a negative return on equity of 3.05% and a negative net margin of 4.65%. The firm had revenue of $356.62 million during the quarter, compared to analysts' expectations of $332.17 million. During the same period in the prior year, the company earned $0.13 earnings per share. The company's quarterly revenue was up 6.4% on a year-over-year basis. As a group, sell-side analysts expect that UiPath, Inc. will post -0.17 EPS for the current fiscal year.

Insider Activity at UiPath

In related news, CFO Ashim Gupta sold 98,795 shares of the firm's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $12.01, for a total transaction of $1,186,527.95. Following the sale, the chief financial officer now owns 987,322 shares of the company's stock, valued at $11,857,737.22. This trade represents a 9.10% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CAO Hitesh Ramani sold 12,500 shares of the company's stock in a transaction dated Thursday, April 3rd. The stock was sold at an average price of $10.19, for a total value of $127,375.00. Following the completion of the transaction, the chief accounting officer now directly owns 314,891 shares of the company's stock, valued at approximately $3,208,739.29. The trade was a 3.82% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 201,295 shares of company stock valued at $2,423,153 over the last ninety days. 23.19% of the stock is owned by corporate insiders.

UiPath Profile

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Further Reading

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double
The Next Palantir? AI-Defense Stock Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines